Title : Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.

Pub. Date : 2021 Oct

PMID : 34417675






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the subset of BRCA1/2 carriers, the ORR was 32% among platinum-naive patients versus 9% among platinum-exposed patients. Platinum BRCA1 DNA repair associated Homo sapiens